Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.05 USD | -0.52% | -1.71% | -35.42% |
Apr. 23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
Apr. 18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
Financials (USD)
Sales 2024 * | 461M | Sales 2025 * | 526M | Capitalization | 1.12B |
---|---|---|---|---|---|
Net income 2024 * | -34M | Net income 2025 * | -27M | EV / Sales 2024 * | 2.28 x |
Net cash position 2024 * | 61.14M | Net cash position 2025 * | 78.13M | EV / Sales 2025 * | 1.97 x |
P/E ratio 2024 * |
-31.4
x | P/E ratio 2025 * |
-40.2
x | Employees | 1,200 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on AtriCure, Inc.
1 day | -0.52% | ||
1 week | -1.71% | ||
Current month | -24.23% | ||
1 month | -19.04% | ||
3 months | -31.36% | ||
6 months | -35.83% | ||
Current year | -35.42% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 46 | 14-06-30 |
Chief Tech/Sci/R&D Officer | 52 | 17-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Prange
BRD | Director/Board Member | 60 | 19-12-03 |
Michael Carrel
CEO | Chief Executive Officer | 53 | 12-11-01 |
Sven Wehrwein
BRD | Director/Board Member | 73 | 16-11-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 509 M€ | -.--% | ||
0.03% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 23.05 | -0.52% | 419,955 |
24-04-23 | 23.17 | +2.03% | 947,750 |
24-04-22 | 22.71 | -2.11% | 684,150 |
24-04-19 | 23.2 | -0.81% | 470,018 |
24-04-18 | 23.39 | -0.26% | 976,148 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.42% | 1.12B | |
-2.89% | 185B | |
-2.43% | 107B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B |
- Stock Market
- Equities
- ATRC Stock